Patents
Patents for C07D 221 - Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups (10,931)
08/2003
08/26/2003US6610284 Preparation for prevention and healing of inflammation affections
08/21/2003WO2003068748A1 Novel pyridine- and quinoline-derivatives
08/21/2003WO2003068212A1 Use of sodium/hydrogen exchange inhibitors from the treatment of thrombotic and inflammatory diseases
08/21/2003WO2002036573A3 8- substituted-2, 6-methano-3-benzazocines and 3-substituted morphinanes as opioid receptor binding agents
08/21/2003US20030158415 Binds to opioid receptors
08/21/2003CA2476446A1 Use of sodium/hydrogen exchange inhibitors from the treatment of thrombotic and inflammatory diseases
08/20/2003EP1336600A2 Dimer-selective RXR modulators and methods for their use
08/20/2003EP1173519B1 Novel carbopyronine fluorescence dyes
08/20/2003EP0923542B1 Aryl substituted cyclic amines as selective dopamine d3 ligands
08/20/2003EP0734724B1 Process for the preparation of a phencynonate hydrochloride of alpha-configuration
08/20/2003CN1437584A Tricyclic protein kinase inhibitors
08/19/2003US6608202 One pot proscess including alkarylating 2-carboxy-3-methyl-pyridine, converting to acid chloride and cyclizing; anti-histamine precursors
08/19/2003US6608083 Treatment and/or prophylaxis of convulsive disorders, renal disorders, urinary incontinence, ocular inflammation, eating disorders, inflammatory pain, allergic rhinitis, psoriasis,neurodegenerative disorders, Huntington's disease,
08/19/2003US6608080 Morphan derivatives or salts thereof and medicinal compositions containing the same
08/19/2003US6608066 Tissue factor antagonists and methods of use thereof
08/14/2003WO2003066599A1 N-allyloxyethyl-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines and the use of the same as pharmaceuticals
08/14/2003WO2003066597A2 Guanidino compounds
08/14/2003US20030153763 Indolinyl, 1,2,3,4-tetrahydroquinolinyl, 1,2,3,4-tetrahydro isoquinolinyl, benz(cd)indolinyl and 5,6-dihydrophen anthridinyl compounds; treating neurodegenerative disorders
08/14/2003US20030153576 Such as amino-indazoles for treatment of central nervous system disorders
08/14/2003CA2474687A1 N-allyloxyethyl-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines and the use of thereof as medicaments
08/13/2003CN1436193A Antitumoral ecteinascidin derivs
08/13/2003CN1436174A HMG-CoA reductase inhibitors and their use as medicaments for treatment of cholesterol related diseases
08/12/2003US6605632 Affinity for melatonin receptors
08/12/2003US6605621 Monomeric and dimeric heterocycles, and therapeutic uses thereof
08/12/2003US6605610 Aryl fused azapolycyclic compounds
08/07/2003US20030149091 For therapy of inflammatory bowel disease, ulcerative colitis, pyoderma gangrenosum, Crohn's disease, irritable bowel syndrome, spastic dystonia, chronic pain, acute pain, celiac sprue, pouchitis, vasoconstriction, anxiety, panic disorder
08/07/2003US20030149073 Cycloalkano-indole and -azaindole derivatives
08/07/2003US20030149068 Use of chrysanthone A for the preparation of a medicament with antiangiogenic activity
08/06/2003EP1332146A2 Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors
08/06/2003EP1332133A1 Metabotropic glutamate receptor antagonists
08/06/2003EP0804419B1 Quinoline derivatives as tachykinin nk 3 receptor antagonists
08/06/2003CN1434802A New azabicyclooctane derivatives useful in the treatment of cardiac arrhythmias
08/06/2003CN1117092C Azadicyclic compound, its medicinal composition and medicinal use
08/05/2003US6602880 3-phenyl-3,7-diazabicyclo[3.3.1] nonane compounds, process for preparing them, pharmaceutical compositions containing them and use thereof to inhibit cardiac arrhythmia
08/05/2003US6602871 Thrombin or factor Xa inhibitors
08/05/2003CA2077708C Cyclic nitrones
07/2003
07/31/2003WO2003062202A2 Method for the production of substituted 1,2,3,4-tetrahydroisoquinoline-2-carboxylic acids
07/31/2003WO2002018361A3 Compounds having activity as inhibitors of cytochrome p450rai
07/31/2003US20030144319 2-Substituted piperidine analogs as excitatory amino acid receptor antagonists that block N-methyl-D-aspartic acid receptors; neuroprotective agents; stroke; brain disorders; antiischemic agents; anxiolytic agents; headaches; analgesics
07/31/2003US20030144314 Process of synthesis of a tricyclic ketone intermediate
07/31/2003US20030144313 Non-steroidal, tetracylic compounds for estrogen-related treatments
07/31/2003US20030144289 Dopamine and serotonin reuptake antagonists, used for the prophylaxis of drug abuse or dependence, neurodegenerative diseases or as antidepressants
07/31/2003US20030144137 For use as catalysts in asymmetric reactions, such as, hydrogenation, hydride transfer, allylic alkylation, hydrosilylation, hydroboration, hydrovinylation, hydroformylation, olefin metathesis, hydrocarboxylation
07/30/2003CN1116366C Pyridone-methide azo dyestuffs
07/29/2003CA2266357C Pictet-spengler reaction for the synthesis of tetrahydroisoquinolines and related heterocyclic compounds
07/24/2003US20030139431 Guanidines which are agonist/antagonist ligands for neuropeptide FF (NPFF) receptors
07/23/2003CN1115342C Hypnotic beta-carboline derivatives, process for their prepn. and their use as medicinal products
07/17/2003WO2003057697A1 Derivatives of 5-(pyridin-3-yl)-1-azabicyclo[3.2.1]octane, the preparation thereof and the application of same in therapeutics
07/17/2003WO2003057145A2 SUBSTITUTED 4,9-DIHYDROCYCLOPENTA[imn]PHENANTHRIDINE-5-ONES DERIVATIVES THEREOF AND THEIR USES
07/17/2003US20030135045 Glycoprotein IIb/IIIa antagonists
07/16/2003EP1326867A2 Bridged piperazine derivatives
07/16/2003EP1326865A2 Aza- and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors
07/16/2003EP1326841A1 Pyridinone derivatives for treatment of atherosclerosis
07/16/2003CN1114608C Novel camptothecine analogues, prepn. method therefor, use thereof, and pharmaceutical compositions contg. same
07/15/2003US6593474 Adrenergic blocking agents
07/15/2003US6593348 Opiate compounds, methods of making and methods of use
07/15/2003US6593335 Disease than can be ameliorated with a potassium channel opener in a host mammal, comprising administering to the mammal in need thereof a therapeutically effective amount of the compound of claim 1; said disease is epilepsy, Raynaud's
07/10/2003US20030130261 Central nervous system disorders; psychological disorders; inflammatory bowel disorders
07/10/2003US20030130260 Aryl fused azapolycyclic compounds
07/09/2003CN1429212A Uses of thaliporphine or its derivatives in treatment of cardiac diseases and preparation of same
07/09/2003CN1428145A Quinoline derivative as tachykinin NK3 receptor agonist
07/09/2003CN1113872C Tricyclicbenzo [e] isoindole and benzo [h] isoquinoline
07/03/2003WO2003053915A2 Compounds for the treatment of inflammatory disorders
07/03/2003WO2002079189A3 Spiroisoquinoline compounds, methods for their preparation and intermediates
07/02/2003EP1323711A1 Novel phenylalanine derivatives
07/02/2003EP1323160A1 Optical data carrier containing a phthalocyanine colouring agent as a light absorbing compound in the information layer
07/02/2003EP1322906A1 Optical data storage device containing a co-phthalocyanin complex in the optically writable information layer
07/02/2003EP1322631A2 Methods of providing and using compounds ( retinoids ) having activity as inhibitors of cytochrome p450rai
07/02/2003EP1171444B1 Pyrido-thieno-diazepines, method for the production thereof and pharmaceutical compositions containing said pyrido-thieno-diazepines
07/02/2003CN1113058C Improved method for preparing pharmaceutically valuable norbenzomorphane derivatives
07/01/2003US6586448 Cholesteryl ester transfer protein inhibitors used as antilipemic agents for prophylaxis of cardiovascular disorders
07/01/2003US6586187 2-benzyloxycarbonylamino-3-(2-(4-(2-(3-benzylureido)-ethyl) -piperazin-1-yl)acetylamino)-propionic acid, for example; method of synthesis using Wang resins; various uses including anticancer, antiinflammatory and antiviral agents
06/2003
06/26/2003WO2003051880A1 1,8-annelated quinoline derivatives substituted with carbon-linked triazoles as farnesyl transferase inhibitors
06/26/2003WO2003051842A2 Compositions decreasing activity of hormone-sensitive lipase
06/26/2003WO2003051841A2 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
06/26/2003WO2003051826A1 3-phenyl-2-arylalkylthiopropionic acid derivatives as selective agonists of ppar-alpha
06/26/2003US20030119868 Gyrase inhibitors and uses thereof
06/26/2003US20030119858 Conformationally constrained compounds as pharmaceutical agents
06/26/2003CA2468413A1 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
06/25/2003EP1320367A1 Process for the preparation of dinapsoline
06/25/2003EP1029016A4 Novel chemiluminescent labeling compounds
06/25/2003CN1425652A Aporphine alkaloids with hepatitis virus inhibiting activity
06/25/2003CN1112365C Piperidine derivatives and preparing method and use
06/25/2003CN1112354C Stereo specific prepn. of chiral 1-aryl-and 1-heteroaryl-2-substituted ethyl-2-amines
06/24/2003US6583174 Bi-cyclic compound dissolved in a glyceride; 7-((1R,3R,6R,7R)-3-(1,1-difluoropentyl)-3-hydroxy-2-oxabicyclo(4,3,0)nonane -8-one-7-yl)heptanoic acid
06/24/2003US6583168 Sulfonated diarylrhodamine dyes
06/24/2003US6582879 Reactive photo acid-generating agent and heat-resistant photoresist composition with polyamide precursor
06/19/2003WO2000077000A9 New bispidine compounds useful in the treatment of cardiac arrhythmias
06/19/2003US20030114679 Selective hydrogenation of amino-substituted fused bicyclic aromatic ring system, preparation of racemic amino substituted fused bicyclic ring system via nitrosation, enzymatic resolution of racemic mixture to produce (R)- and (S)-forms
06/19/2003US20030114485 Killing drug resistant cancer cells; controlling cell differentiation
06/19/2003US20030114458 Antibacterial agents
06/19/2003US20030113665 Optical data medium containing, in the information layer, a dye as a light-absorbing compound
06/18/2003EP1318995A2 Pyridinone and pyridinethione derivatives having hiv inhibiting properties
06/18/2003EP1318978A2 N-acylsulfonamide apoptosis promoters
06/18/2003EP1318811A1 Cyclopentyl modulators of chemokine receptor activity
06/18/2003CN1425013A Phenyl substituted 4-hydroxy tetrahydropyridone
06/18/2003CN1425006A Synthesis of intermediates useful in preparing tricyclic compounds
06/17/2003US6579883 Fluorinated 3,4-dihydroquinoline derivatives used as NOS inhibitors
06/17/2003US6579881 Muscle relaxants, antiserotonine agent
06/17/2003US6579633 Metal sulfonates of metal complexes of hydroxy- and mercapto-quinolines, benzoxazoles, benzothiazoles, benzotriazoles, benzoselenazoles, benzotellurazoles and phenanthridines
1 ... 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 ... 110